Another study analyzed differential expression of FSCN1 in classic Hodgkin lymphoma (CHL), anaplastic large cell lymphoma (ALCL), and diffused large B-cell lymphoma (DLBCL); the study showed that FSCN1 is significantly upregulated in CHL as compared to DLBCL and ALCL, indicating a role of FSCN1 in the differential diagnosis of CHL against ALCL and DLBCL [177]. This evidence concerns the gene FSCN1 and anaplastic large cell lymphoma.